-
1دورية أكاديمية
المؤلفون: Al-Nawas, Bilal, Lambert, France, Andersen, Sanne Werner Møller, Bornstein, Michael M, Gahlert, Michael, Jokstad, Asbjorn, Jung, Junho, Kwon, Yong-Dae, Laleman, Isabelle, Oteri, Giacomo, Roehling, Stefan, Schiegnitz, Eik, Takeda, Yukihiro, Terheyden, Hendrik
المساهمون: d‐BRU - Dental Biomaterials Research Unit - ULiège, BE
المصدر: Clinical Oral Implants Research, 34 Suppl 26 (S26), 169 - 176 (2023-09)
مصطلحات موضوعية: anti-resorptive drugs, biomaterials, drug delivery, peri-implant tissue integration, pharmacology, structural biology, tissue implant interactions, tissue physiology, wound healing, zirconium oxide, Bone Density Conservation Agents, Titanium, Dental Implants, Alloys, Humans, Bone Density Conservation Agents/adverse effects, Oral Surgery, Human health sciences, Dentistry & oral medicine, Sciences de la santé humaine, Dentisterie & médecine buccale
Relation: https://onlinelibrary.wiley.com/doi/pdf/10.1111/clr.14135; urn:issn:0905-7161; urn:issn:1600-0501
URL الوصول: https://orbi.uliege.be/handle/2268/312712
-
2
المؤلفون: Mina Nicole Händel, Isabel Cardoso, Cecilie von Bülow, Jeanett Friis Rohde, Anja Ussing, Sabrina Mai Nielsen, Robin Christensen, Jean-Jacques Body, Maria Luisa Brandi, Adolfo Diez-Perez, Peyman Hadji, Muhammad Kassim Javaid, Willem Frederik Lems, Xavier Nogues, Christian Roux, Salvatore Minisola, Andreas Kurth, Thierry Thomas, Daniel Prieto-Alhambra, Serge Livio Ferrari, Bente Langdahl, Bo Abrahamsen
المساهمون: Rheumatology, AII - Inflammatory diseases, AMS - Musculoskeletal Health, AMS - Tissue Function & Regeneration, Medical Informatics
المصدر: BMJ (Clinical research ed.), 381:e068033. BMJ Publishing Group
Händel, M N, Cardoso, I, von Bülow, C, Rohde, J F, Ussing, A, Nielsen, S M, Christensen, R, Body, J-J, Brandi, M L, Diez-Perez, A, Hadji, P, Javaid, M K, Lems, W F, Nogues, X, Roux, C, Minisola, S, Kurth, A, Thomas, T, Prieto-Alhambra, D, Ferrari, S L, Langdahl, B & Abrahamsen, B 2023, ' Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women : systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials ', BMJ (Clinical research ed.), vol. 381, e068033, pp. e068033 . https://doi.org/10.1136/bmj-2021-068033
BMJ. BMJ Publishing Group
Händel, M N, Cardoso, I, Von Bülow, C, Rohde, J F, Ussing, A, Nielsen, S M, Christensen, R, Body, J J, Brandi, M L, Diez-Perez, A, Hadji, P, Javaid, M K, Lems, W F, Nogues, X, Roux, C, Minisola, S, Kurth, A, Thomas, T, Prieto-Alhambra, D, Ferrari, S L, Langdahl, B & Abrahamsen, B 2023, ' Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women : systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials ', BMJ, vol. 381, e068033 . https://doi.org/10.1136/bmj-2021-068033مصطلحات موضوعية: Osteoporotic Fractures/prevention & control, Network Meta-Analysis, General Medicine, Postmenopause, Diphosphonates/adverse effects, Osteoporosis, Postmenopausal/complications, Humans, Spinal Fractures, Female, Bone Density Conservation Agents/adverse effects, Denosumab/adverse effects, Risk Reduction Behavior, Osteoporosis/drug therapy, Randomized Controlled Trials as Topic, Receptor, Parathyroid Hormone, Type 1
وصف الملف: application/pdf
-
3
المصدر: Sølling, A S, Harsløf, T, Bruun, N H & Langdahl, B 2021, ' The predictive value of bone turnover markers during discontinuation of alendronate : the PROSA study ', Osteoporosis International, vol. 32, no. 8, pp. 1557-1566 . https://doi.org/10.1007/s00198-021-05835-4
مصطلحات موضوعية: Male, 0301 basic medicine, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Treatment discontinuation, Osteoporosis, Urology, 030209 endocrinology & metabolism, Reference range, Bone remodeling, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Trabecular bone score, Bone Density, Biochemical markers of bone turnover, medicine, Humans, Bone Density Conservation Agents/adverse effects, DXA, Lumbar Vertebrae, Alendronate, business.industry, Osteoporosis, Postmenopausal/drug therapy, Alendronate/adverse effects, medicine.disease, Antiresorptives, Discontinuation, Osteopenia, Clinical trial, Orthopedic surgery, Female, Bone Remodeling, 030101 anatomy & morphology, business, Biomarkers, Cohort study
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bd9aa6cdf632a5cc20f9727abccf333
https://vbn.aau.dk/da/publications/d18ccd45-b6ab-4b67-bd1a-771c4aafa18e -
4
المصدر: Nederlands Tijdschrift voor Geneeskunde. 162(21)
مصطلحات موضوعية: Diphosphonates/administration & dosage, Bone/chemically induced, Bone Density, Spinal Fractures/chemically induced, Humans, Osteoporosis, Female, Bone Density Conservation Agents/adverse effects, Osteoporosis/complications, Postmenopausal/drug therapy, Denosumab/adverse effects, Fractures
URL الوصول: https://explore.openaire.eu/search/publication?articleId=dris___01423::18799e54a432206952b0cc98154dda14
https://research.rug.nl/en/publications/6ae86351-405e-4ad5-96b6-e9d785e3af70 -
5
المؤلفون: Daniel Prieto-Alhambra, Irene Petersen, Antonella Delmestri, Cyrus Cooper, T P van Staa, Samuel Hawley, Muhammad Javaid, Elisa Martín-Merino, S Khalid, Ana Llorente-García, Arturo Álvarez-Gutiérrez, Andrew Judge
المساهمون: Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
المصدر: Martín-Merino, E, Petersen, I, Hawley, S, Álvarez-Gutierrez, A, Khalid, S, Llorente-Garcia, A, Delmestri, A, Javaid, M K, Van Staa, T P, Judge, A, Cooper, C & Prieto-Alhambra, D 2018, ' Risk of venous thromboembolism among users of different anti-osteoporosis drugs : a population-based cohort analysis including over 200,000 participants from Spain and the UK ', Osteoporosis International, vol. 29, no. 2, pp. 467–478 . https://doi.org/10.1007/s00198-017-4308-5
Osteoporosis International, 29(2), 467. Springer Londonمصطلحات موضوعية: Male, Endocrinology, Diabetes and Metabolism, Thiophenes/adverse effects, Cohort Studies, 0302 clinical medicine, Strontium ranelate, Teriparatide, 80 and over, Electronic health records, 030212 general & internal medicine, Bone Density Conservation Agents/adverse effects, Denosumab/adverse effects, Aged, 80 and over, Alendronate, Bone Density Conservation Agents, Diphosphonates, United Kingdom/epidemiology, Hazard ratio, Alendronate/adverse effects, Venous Thromboembolism, Pharmacoepidemiology, Middle Aged, Primary care, Diphosphonates/adverse effects, Denosumab, Cohort, Spain/epidemiology, Female, medicine.drug, Cohort study, Venous thromboembolism, medicine.medical_specialty, 030209 endocrinology & metabolism, Thiophenes, Risk Assessment, Bazedoxifene, 03 medical and health sciences, Primary Health Care/methods, Teriparatide/adverse effects, Internal medicine, medicine, Humans, Anti-osteoporosis medication, Risk Assessment/methods, Aged, Primary Health Care, business.industry, United Kingdom, Spain, Venous Thromboembolism/chemically induced, business
وصف الملف: application/pdf
-
6
المؤلفون: Martin Schimmel, Frauke Müller, Murali Srinivasan, Gerald McKenna
المصدر: Schimmel, M, Srinivasan, M, McKenna, G & Muller, F 2018, ' Effect of advanced age, and/or systemic medical conditions on dental implant survival: a systematic review and meta-analysis ', clinical oral implants research, vol. 29, no. S16, pp. 311-330 . https://doi.org/10.1111/clr.13288
Clinical Oral Implants Research, Vol. 29 (2018) pp. 311-330
Schimmel, Martin; Srinivasan, Murali; McKenna, Gerald; Müller, Frauke (2018). Effect of advanced age and/or systemic medical conditions on dental implant survival: A systematic review and meta-analysis. Clinical oral implants research, 29(S16), pp. 311-330. Wiley-Blackwell 10.1111/clr.13288 <http://dx.doi.org/10.1111/clr.13288>مصطلحات موضوعية: Lung Diseases, medicine.medical_treatment, Osteoporosis, Alveolar Bone Loss, Disease, Lung Diseases/complications, 0302 clinical medicine, Parkinson Disease/complications, Risk Factors, Neoplasms, 80 and over, Medicine, Neoplasms/complications, Bone Density Conservation Agents/adverse effects, Dental Restoration Failure, Neoplasm Metastasis, Dental implant, 610 Medicine & health, Stroke, Depression (differential diagnoses), Aged, 80 and over, Bone Density Conservation Agents, Dental Implantation, Endosseous, Age Factors, Parkinson Disease, ddc:617.6, Type 2/complications, Dental Implantation, Cardiovascular Diseases, 030220 oncology & carcinogenesis, Meta-analysis, Oral Surgery, Endosseous, medicine.medical_specialty, Cardiovascular Diseases/complications, Xerostomia, Osteoporosis/complications/therapy, Diabetes Complications, 03 medical and health sciences, SDG 3 - Good Health and Well-being, Internal medicine, Diabetes Mellitus, Dementia, Humans, Aged, Dental Implants, Radiotherapy, business.industry, 030206 dentistry, Xerostomia/complications, medicine.disease, Survival Analysis, Radiotherapy/adverse effects, Diabetes Mellitus, Type 2, Implant, Dementia/complications, business
وصف الملف: application/pdf
-
7دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
8
المؤلفون: Erik Lerkevang Grove, Peter Vestergaard, Bo Abrahamsen
المصدر: Abrahamsen, B, Grove, E & Vestergaard, P 2014, ' Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate ', Osteoporosis International, vol. 25, no. 2, pp. 757-762 . https://doi.org/10.1007/s00198-013-2469-4
Abrahamsen, B, Grove, E L & Vestergaard, P 2013, ' Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate ', Osteoporosis International . https://doi.org/10.1007/s00198-013-2469-4مصطلحات موضوعية: inorganic chemicals, musculoskeletal diseases, Male, medicine.medical_specialty, Databases, Factual, Epidemiology, Denmark, Endocrinology, Diabetes and Metabolism, Osteoporosis, Thiophenes, Thiophenes/adverse effects, Strontium ranelate, Risk Factors, Cause of Death, Internal medicine, medicine, Humans, Bone Density Conservation Agents/adverse effects, Registries, Mortality, Risk factor, Drug safety, Stroke, Aged, Cause of death, Aged, 80 and over, Bone Density Conservation Agents, Drug Utilization/statistics & numerical data, Vascular disease, business.industry, Middle Aged, Cardiovascular Diseases/chemically induced, medicine.disease, Denmark/epidemiology, Drug Utilization, Rheumatology, Surgery, Treatment Outcome, Cardiovascular Diseases, Female, business, Osteoporosis/drug therapy, medicine.drug
-
9
المؤلفون: Reyes, Carlen, Hitz, Mette, Prieto-Alhambra, Daniel, Abrahamsen, Bo
المصدر: Reyes, C, Hitz, M, Prieto-Alhambra, D & Abrahamsen, B 2016, ' Risks and Benefits of Bisphosphonate Therapies ', Journal of Cellular Biochemistry, vol. 117, no. 1, pp. 20-28 . https://doi.org/10.1002/jcb.25266
مصطلحات موضوعية: OSTEOCLAST, Diphosphonates/adverse effects, Humans, Bone Density Conservation Agents/adverse effects, BONE, OSTEOPOROSIS, Risk Assessment, Osteoporosis/drug therapy
URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______3062::f3d9de614595075074e7f8afbb6bda54
http://www.scopus.com/inward/record.url?scp=84957309787&partnerID=8YFLogxK -
10
المؤلفون: Cesar Libanati, Michelle N. Bradley, Nadia Daizadeh, Dan Mellström, Marc-Antoine Krieg, Heinrich Resch, José Andrés Román Ivorra, Eric Vittinghoff, M. Austin, Maria Luisa Brandi, Z. Man, Socrates E. Papapoulos, Christian Roux, Steven R. Cummings, Sebastião Cezar Radominski, Roland Chapurlat, Andreas Grauer, Edward Czerwiński, Henry G. Bone, Jean-Yves Reginster, Jacques P. Brown
المصدر: Journal of Bone and Mineral Research, vol. 27, no. 3, pp. 694-701
Journal of Bone and Mineral Researchمصطلحات موضوعية: medicine.medical_specialty, BONE TURNOVER MARKERS, Bone density, Endocrinology, Diabetes and Metabolism, PIVOTAL FRACTURE TRIAL EXTENSION, Osteoporosis, Antibodies, Monoclonal, Humanized, law.invention, Bone remodeling, Placebos, Double-Blind Method, Randomized controlled trial, Bone Density, law, Internal medicine, medicine, Humans, Orthopedics and Sports Medicine, Aged, Bone mineral, DENOSUMAB, Cross-Over Studies, Bone Density Conservation Agents, business.industry, Antibodies, Monoclonal, medicine.disease, FRACTURE, Surgery, Postmenopause, Antibodies, Monoclonal/adverse effects, Antibodies, Monoclonal/therapeutic use, Biological Markers/blood, Bone Density Conservation Agents/adverse effects, Bone Density Conservation Agents/therapeutic use, Female, Osteoporosis/drug therapy, Denosumab, Cohort, Original Article, business, Osteonecrosis of the jaw, Biomarkers, BONE MINERAL DENSITY, medicine.drug
وصف الملف: application/pdf
Full text from British Medical Journal